Markers of Systemic Inflammatory Response Are Prognostic Factors in Patients with Pancreatic Neuroendocrine Tumors (PNETs): A Prospective Analysis

被引：0
|
作者：
Gaitanidis, Apostolos [1 ]
Patel, Dhaval [1 ]
Nilubol, Naris [1 ]
Tirosh, Amit [1 ]
Sadowski, Samira [1 ]
Kebebew, Electron [1 ]
机构：
[1] NCI, Endocrine Oncol Branch, NIH, Bethesda, MD 20892 USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS | 2017年 / 225卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：S70 / S71
页数：2
相关论文
共 50 条
  • [21] Impact of systemic and tumor lipid metabolism on everolimus efficacy in advanced pancreatic neuroendocrine tumors (pNETs)
    Vernieri, Claudio
    Pusceddu, Sara
    Fuca, Giovanni
    Indelicato, Pietro
    Centonze, Giovanni
    Castagnoli, Lorenzo
    Ferrari, Elisa
    Ajazi, Arta
    Pupa, Serenella
    Casola, Stefano
    Foiani, Marco
    Mazzaferro, Vincenzo
    Pruneri, Giancarlo
    Milione, Massimo
    de Braud, Filippo
    INTERNATIONAL JOURNAL OF CANCER, 2019, 144 (07) : 1704 - 1712
  • [22] Outcomes of patients treated with capecitabine and temozolamide (CapTem) for advanced pancreatic neuroendocrine tumors (PNETs) and non-PNETs
    Peixoto, Renata D'Alpino
    Noonan, Krista
    Kennecke, Hagen F.
    Lim, Howard John
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
  • [23] Systemic Treatments and Prognostic Factors in Chinese Patients with Progressive Advanced Well-Differentiated Pancreatic Neuroendocrine Tumors
    Cheng, Y.
    Gao, H.
    Bai, C. M.
    Ying, H.
    Meng, C.
    Yan, X.
    NEUROENDOCRINOLOGY, 2016, 103 : 87 - 87
  • [24] Prospective analysis of clinical outcomes and prognostic factors in patients with ne 11 neuroendocrine tumors (NETs)
    Ter-Minassian, M.
    Frauenhoffer, C. S.
    Hooshmand, S. M.
    Asomaning, K.
    Lin, X.
    Chan, J. A.
    Christiani, D. C.
    Kulke, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [25] Clinical Implications of Systemic Inflammatory Response Markers as Independent Prognostic Factors in Colorectal Cancer Patients
    Paik, Kwang Yeol
    Lee, In Kyu
    Lee, Yoon Suk
    Sung, Na Young
    Kwon, Taek Soo
    CANCER RESEARCH AND TREATMENT, 2014, 46 (01): : 65 - 73
  • [26] A prospective evaluation of the systemic inflammatory response as a prognostic indicator in resectable pancreatic malignancy
    Logue, Jennifer
    Denley, Simon
    Edwards, Joanne
    Mcmillan, Donald
    Imrie, Clement
    Carter, Ross
    Mckay, Colin
    GASTROENTEROLOGY, 2007, 132 (04) : A119 - A119
  • [27] Value of markers of systemic inflammation for the prediction of postoperative progression in patients with pancreatic neuroendocrine tumors
    Yang, Liu
    Fu, Mengfei
    Yu, Li
    Wang, Hanyu
    Chen, Xiao
    Sun, Hui
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15
  • [28] CHARACTERISTICS AND SURVIVAL OUTCOMES OF PANCREATIC NEUROENDOCRINE TUMORS (PNETS) IN YOUNG PATIENTS (<50 YRS)
    Marvil, Charles E.
    Sundar, Preeyanka R.
    Orr, Jordan
    Patel, Vaishali
    Keilin, Steven
    Willingham, Field F.
    Switchenko, Jeffrey
    Chawla, Saurabh
    GASTROENTEROLOGY, 2023, 164 (06) : S606 - S606
  • [29] BRAF mutations in patients with well-differentiated pancreatic neuroendocrine tumors (WD pNETs)
    Raj, Nitya Prabhakar
    Meyers, Paul A.
    Saltz, Leonard
    Reidy, Diane Lauren
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [30] Prognostic value of systemic inflammatory response markers in patients with intrahepatic cholangiocarcinoma
    Zhang, Chenyue
    Wang, Haiyong
    Ning, Zhouyu
    Xu, Litao
    Zhuang, Liping
    Wang, Peng
    Meng, Zhiqiang
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (06): : 11502 - 11509
12345